FLT3L-Dependent Dendritic Cells Control Tumor Immunity by Modulating Treg and NK Cell Homeostasis

FLT3-L-dependent classical dendritic cells (cDCs) recruit anti-tumor and tumor-protecting lymphocytes. Investigators evaluated cancer growth in mice with low, normal, or high levels of cDCs.